Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 151 - 160 of 1441 shown below

  • Ganem, G

    R Bugat, A Bataillard, T Lesimple, J J Voigt, S Culine, A Lortholary, Y Merrouche, G Ganem, M C Kaminsky, S Negrier, M Perol, C Laforêt, P Bedossa, G Bertrand, J M Coindre and K Fizazi

    Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)

    doi:10.1038/sj.bjc.6601085

    Abstract | Full article | PDF

  • Ganesan, A

    L Nolan, P W M Johnson, A Ganesan, G Packham and S J Crabb

    Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?

    advance online publication, 2008-08-19 00:00:00.000;

    doi:10.1038/sj.bjc.6604557

    Abstract | Full article | PDF

  • Ganesan, R

    S A Hussain, R Ganesan, L Hiller, P G Murray, M M El-Magraby, L Young and N D James

    Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder

    doi:10.1038/sj.bjc.6600765

    Abstract | Full article | PDF

  • S A Hussain, R Ganesan, G Reynolds, L Gross, A Stevens, J Pastorek, P G Murray, B Perunovic, M S Anwar, L Billingham, N D James, D Spooner, C J Poole, D W Rea and D H Palmer

    Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer

    doi:10.1038/sj.bjc.6603530

    Abstract | Full article | PDF

  • Ganesan, T S

    P H Jones, R D Burnett, I Fainaru, P Nadolny, P Walker, Z Yu, D Tang-Liu, T S Ganesan, D C Talbot, A L Harris and G J S Rustin

    A phase 1 study of tazarotene in adults with advanced cancer

    doi:10.1038/sj.bjc.6601169

    Abstract | Full article | PDF

  • C Han, J P Braybrooke, G Deplanque, M Taylor, D Mackintosh, K Kaur, K Samouri, T S Ganesan, A L Harris and D C Talbot

    Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents

    doi:10.1038/sj.bjc.6601218

    Abstract | Full article | PDF

  • P H Jones, K Christodoulos, N Dobbs, P Thavasu, F Balkwill, A D Blann, G J Caine, S Kumar, A J Kakkar, N Gompertz, D C Talbot, T S Ganesan and A L Harris

    Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer

    advance online publication, 2004-05-25 00:00:00.000;

    doi:10.1038/sj.bjc.6601897

    Abstract | Full article | PDF

  • G Deplanque, S Madhusudan, P H Jones, S Wellmann, K Christodoulos, D C Talbot, T S Ganesan, A Blann and A L Harris

    Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma

    advance online publication, 2004-10-19 00:00:00.000;

    doi:10.1038/sj.bjc.6602126

    Abstract | Full article | PDF

  • N C Levitt, D J Propper, S Madhusudan, J P Braybrooke, C Echeta, R te Poele, S L Davies, E Flanagan, I D Hickson, S Joel and T S Ganesan

    Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer

    advance online publication, 2005-06-14 00:00:00.000;

    doi:10.1038/sj.bjc.6602657

    Abstract | Full article | PDF

  • S S Sundar, H Zhang, P Brown, S Manek, C Han, K Kaur, M F L Charnock, D Jackson and T S Ganesan

    Role of lymphangiogenesis in epithelial ovarian cancer

    advance online publication, 2006-05-09 00:00:00.000;

    doi:10.1038/sj.bjc.6603144

    Abstract | Full article | PDF

  • D J Propper, N C Levitt, K O'Byrne, J P Braybrooke, D C Talbot, T S Ganesan, C H Thompson, B Rajagopalan, T J Littlewood, R M Dixon and A L Harris

    Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer

    doi:10.1054/bjoc.2000.1138

    Abstract | Full article | PDF

  • D J Propper, J P Braybrooke, N C Levitt, K O'Byrne, K Christodoulos, C Han, D C Talbot, T S Ganesan and A L Harris

    Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine

    doi:10.1054/bjoc.2000.1141

    Abstract | Full article | PDF

  • J P Braybrooke, D J Propper, K J O'Byrne, M I Koukourakis, A V Patterson, S Houlbrook, S D Love, S Varcoe, M Taylor, T S Ganesan, D C Talbot and A L Harris

    Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha

    doi:10.1054/bjoc.2000.1230

    Abstract | Full article | PDF

  • Gangadharan, P

    P A Jayalekshmi, P Gangadharan, S Akiba, R R K Nair, M Tsuji and B Rajan

    Tobacco chewing and female oral cavity cancer risk in Karunagappally cohort, India

    doi:10.1038/sj.bjc.6604907

    Abstract | Full article | PDF

  • Ganganagari, J R

    J Cummings, M Ranson, E LaCasse, J R Ganganagari, M St-Jean, G Jayson, J Durkin and C Dive

    Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP

    doi:10.1038/sj.bjc.6603220

    Abstract | Full article | PDF

  • Gangeswaran, R

    T Harada, P Baril, R Gangeswaran, G Kelly, C Chelala, V Bhakta, K Caulee, P C Mahon and N R Lemoine

    Identification of genetic alterations in pancreatic cancer by the combined use of tissue microdissection and array-based comparative genomic hybridisation

    doi:10.1038/sj.bjc.6603563

    Abstract | Full article | PDF

  • Ganju, V

    M Michael, T Price, S Y Ngan, V Ganju, A H Strickland, A Muller, K Khamly, A D Milner, J Dilulio, A Matera, J R Zalcberg and T Leong

    A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer

    advance online publication, 2008-12-16 00:00:00.000;

    doi:10.1038/sj.bjc.6604827

    Abstract | Full article | PDF

  • Ganly, I

    I Ganly, D S Soutar, R Brown and S B Kaye

    p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy

    doi:10.1054/bjoc.1999.0932

    Abstract | Full article | PDF

  • Gannot, G

    G Gannot, I Gannot, H Vered, A Buchner and Y Keisari

    Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma

    doi:10.1038/sj.bjc.6600282

    Abstract | Full article | PDF